A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the dose-limiting toxicity (DLT), maximum tolerated
dose (MTD) and recommended Phase II dose of ixabepilone in combination with capecitabine in
Japanese participants with metastatic breast cancer.